Directory
Montserrat Rué Monné

Montserrat Rué Monné

Degree: PhD

973 702 441
montserrat.rue(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/B-5663-2009

Groups

Publications

  • Pallares, J; Bussaglia, E; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Sanchez-Verde, L; Palacios, J; Prat, J; Matias-Guiu, X

    Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities.

    MODERN PATHOLOGY 18 719-727. .

    [doi:10.1038/modpathol.3800347]

  • Pallares, J; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Palacios, J; Prat, J; Matias-Guiu, X

    Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.

    JOURNAL OF PATHOLOGY 204 569-577. .

    [doi:10.1002/path.1666]

  • Ghobrial, IM; Fonseca, R; Greipp, PR; Blood, E; Rue, M; Vesole, DH; Gertz, MA

    Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study.

    CANCER 101 2593-2598. .

    [doi:10.1002/cncr.20658]

  • Balmana, J; Sanz, J; Bonfill, X; Casado, A; Rue, M; Gich, I; Diez, O; Sabate, JM; Baiget, M; Alonso, MC

    Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio.

    INTERNATIONAL JOURNAL OF CANCER 112 647-652. .

    [doi:10.1002/ijc.20458]

  • Gertz, MA; Rue, M; Blood, E; Kaminer, LS; Vesole, DH; Greipp, PR

    Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98).

    LEUKEMIA & LYMPHOMA 45 2047-2055. .

    [doi:10.1080/10428190410001714043]

  • Torres-Arzayus, MI; de Mora, JF; Yuan, J; Vazquez, F; Branson, R; Rue, M; Sellers, WR; Brown, M

    High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.

    CANCER CELL 6 263-274. .

    [doi:10.1016/j.ccr.2004.06.027]

  • Waber, DP; Silverman, LB; Catania, L; Mautz, W; Rue, M; Gelber, RD; Levy, DE; Goldwasser, MA; Adams, H; Dufresne, A; Metzger, V; Romero, I; Tarbell, NJ; Dalton, VK; Sallan, SE

    Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.

    JOURNAL OF CLINICAL ONCOLOGY 22 2701-2707. .

    [doi:10.1200/JCO.2004.10.173]

  • Li, AH; Rue, M; Zhou, JB; Wang, HJ; Goldwasser, MA; Neuberg, D; Dalton, V; Zuckerman, D; Lyons, C; Silverman, LB; Sallan, SE; Gribben, JG; Dana-Farber Cancer Ist

    Utilization of Ig heavy chain variable, diversity, and joining gene segments in children with B-lineage acute lymphoblastic leukemia: implications for the mechanisms of VDJ recombination and for pathogenesis.

    BLOOD 103 4602-4609. .

    [doi:10.1182/blood-2003-11-3857]

  • Li, AH; Zhou, JB; Zuckerman, D; Rue, M; Dalton, V; Lyons, C; Silverman, LB; Sallan, SE; Gribben, JG

    Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection.

    BLOOD 102 4520-4526. .

    [doi:10.1182/blood-2003-05-1455]

  • Dalton, VK; Rue, M; Silverman, LB; Gelber, RD; Asselin, BL; Barr, RD; Clavell, LA; Hurwitz, CA; Moghrabi, A; Samson, Y; Schorin, M; Tarbell, NJ; Sallan, SE; Cohen, LE

    Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.

    JOURNAL OF CLINICAL ONCOLOGY 21 2953-2960. .

    [doi:10.1200/JCO.2003.03.068]

  • Hwang, SS; Chang, VT; Rue, M; Kasimis, B

    Multidimensional independent predictors of cancer-related fatigue.

    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT 26 604-614. .

    [doi:10.1016/S0885-3924(03)00218-5]

  • Bendell, JC; Domchek, SM; Burstein, HJ; Harris, L; Younger, J; Kuter, I; Bunnell, C; Rue, M; Gelman, R; Winer, E

    Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

    CANCER 97 2972-2977. .

    [doi:10.1002/cncr.11436]

Projects

  • Liquid biopsies for the identification of mechanisms of resistance to PARP inhibitors in BRCA1/2-associated cancers
  • Personalización del cribado del cáncer de mama: Evaluación de su viabilidad y aceptabilidad en el Sistema Nacional de Salud
  • PARTICIPACION DE LAS MUJERES EN LAS DECISIONES Y ESTRATEGIAS DE DETECCION PRECOZ DEL CANCER DE MAMA
  • OPTIMITZACIO DELS PROGRAMES DE CRIBRATGE POBLACIONAL MITJAÇANT MODELS MATEMATICS: APLICACIO AL CRIBRATGE DEL CANCER DE MAMA
  • Optimización de los programas de cribado poblacional mediante modelos matemáticos: aplicación al cribado del cáncer de mama en España
  • Anàlisi de les diferències en la despesa farmacèutica i en la utilització de fàrmacs en la població immigrant i autòctona de la ciutat de Lleida